RIDGEWOOD, NJ, April 5, 2017 — The Valley Heart and Vascular Institute has become the first center in New Jersey to implant to a next-generation heart valve for the treatment of severe aortic stenosis for patients who are at high risk for open heart surgery.
The recently approved Medtronic CoreValve™ Evolut™ Pro valve is designed for transcatheter aortic valve replacement (TAVR), a procedure that allows heart teams to replace a diseased aortic heart valve without open-heart surgery. The procedure provides an important new treatment option for patients with severe, symptomatic aortic valve stenosis for whom traditional valve replacement surgery is not an option. The TAVR procedure was also recently approved for intermediate risk patients.
John Goncalves, M.D., Director of Cardiac Surgery and Surgical Director of Valley’s TAVR Program, and his team performed New Jersey’s first-ever TAVR procedure using the new device on Tuesday, April 4.
Aortic stenosis occurs when calcification builds up in the valve, causing it to narrow. As a result, blood cannot flow through the valve efficiently and the heart must work harder to compensate, which can severely weaken heart muscle. If left untreated it can lead to heart failure and even death.
In a TAVR procedure an expandable heart valve is placed into the body with a tube-based delivery system (catheter). This allows the valve to be inserted through a small cut into an artery in the groin or through the ribs or top of the sternum.
The Evolut PRO device features a unique self-expanding frame and outer wrap that adds surface area contact and achieves advanced valve sealing performance. It is designed to improve sealing and reduce leaking around the edges of the implant.
“The advantage of this innovative design is that is can assist in achieving adequate sealing even in more complex cases,” said Dr. Goncalves. “We are very proud to have been selected by Medtronic based on our expertise to be the first in the area to implant this next-generation valve replacement technology.”
About Valley’s Collaborative TAVR Team
Valley is home to northern New Jersey’s most experienced TAVR team. The physician team includes Dr. Goncalves and structural heart specialists Thomas Cocke, M.D., and Sean Wilson, M.D. Valley is an affiliate of the Cleveland Clinic's Heart & Vascular Institute.
For more information about Valley’s TAVR Program or to make an appointment for an evaluation to see if you are a candidate for this procedure, please call 201-447-8378.